SCHEMBL6650

SCHEMBL6650

CCOC(=O)C1(c2ccc(-c3ccc(-c4onc(C)c4CC(=O)NCCc4ccccc4)cc3)cc2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA3 P22001 1/20 0.43
ABCC3 O15438 1/20 0.42
ABCC4 O15439 1/20 0.42
ABCB11 O95342 1/20 0.42
CYP2C8 P10632 1/20 0.42
CYP2C9 P11712 1/20 0.42
ABCB4 P21439 1/20 0.42
LPAR1 Q92633 1/20 0.42
ABCC2 Q92887 1/20 0.42
SLCO1B3 Q9NPD5 1/20 0.42
SLCO1B1 Q9Y6L6 1/20 0.42
MAPT P10636 1/20 0.41
OPRM1 P35372 5/20 0.40
AKR1C3 P42330 2/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7337 0.92 MAPT (0.44) KCNA3ABCC3ABCC4ABCB11CYP2C8
SCHEMBL6602 0.90 CYP2C9 (0.49) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL6194 0.88 ABCC3 (0.43) KCNA3ABCC3ABCC4ABCB11CYP2C8
SCHEMBL2112 0.88 KCNA3 (0.44) KCNA3ABCC3ABCC4ABCB11CYP2C8
SCHEMBL1916 0.87 KCNA3 (0.45) KCNA3ABCC3ABCC4ABCB11CYP2C8
SCHEMBL6315 0.86 KCNA3 (0.43) KCNA3ABCC3ABCC4ABCB11CYP2C8
SCHEMBL6459 0.86 TSHR (0.47) KCNA3ABCC3ABCC4ABCB11CYP2C8
SCHEMBL7075 0.84 KCNA3 (0.43) KCNA3ABCC3ABCC4ABCB11CYP2C8
SCHEMBL7036 0.84 LPAR1 (0.52) KCNA3ABCC3ABCC4ABCB11CYP2C8
SCHEMBL7377 0.84 LMNA (0.44) KCNA3ABCC3ABCC4ABCB11CYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed